SummaryThe COVID-19 pandemic limits pricing policy options for vaccines. It is therefore necessary to consider what appropriate policy options governments can use to ensure affordable and equitable access to these novel products. Commonly used policies such as fostering competition, generic substitution, and external and internal reference pricing will not work for novel vaccines.

AbstractBackground: To ascertain equity in financing for essential medicines and health supplies (EMHS) in Uganda, this paper explores the relationships among government funding allocations for EMHS, patient load, and medicines availability across facilities at different levels of care.Methods: We collected data on EMHS allocations and availability of selected vital medicines from 43 purposively s

Subscribe to RSS - equity